Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Anika Therapeutics

Anika Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in March of 2022.

Loan Capital Change
Abbott ABT:US USD 14.62B 93M
Agenus AGEN:US USD 12.63M 43K
Enanta Pharmaceuticals ENTA:US USD 1.42M 0
Halozyme Therapeutics HALO:US USD 1.49B 1.61M
Insmed INSM:US USD 1.16B 6.32M
Integra LifeSciences IART:US USD 1.44B 34.52M
J&J JNJ:US USD 34.93B 8.04B
Karyopharm Therapeutics KPTI:US USD 303.02M 201K
Merit Medical Systems MMSI:US USD 186.42M 336K
Peregrine Pharmaceuticals PPHM:US USD 142.06M 129K
Smith & Nephew PLC SN/:LN 2.71B 431M
Stryker SYK:US USD 11.86B 0
Surmodics SRDX:US USD 29.3M 192K
Zimmer Biomet Holdings Inc ZBH:US USD 5.2B 52.6M